News & Trends

Private Equity in Dermatology: Consolidation, Modernization Are on the Horizon

Over the past decade, dermatology practices have become attractive investment opportunities for private equity firms. From 2013 to 2016, dermatologists made up just 1% of U.S. physicians but 9.9% of private equity (PE) investments, according to a 2021 Health Affairs study. By 2017, one in 11 dermatologists practiced in a PE-owned practice. According to Steve […]

Private Equity in Dermatology: Consolidation, Modernization Are on the Horizon Read More »

A View from the Top: Jerin Johnson of Prime Providers

This interview is part of a McGuireWoods series featuring interviews with C-suite leadership of private equity-backed portfolio companies. Jerin Johnson is an accomplished healthcare executive with more than 20 years of experience leading high-growth organizations across the home health and behavioral health sectors. She joined Prime Providers as chief executive officer in February 2024, where

A View from the Top: Jerin Johnson of Prime Providers Read More »

Molina Healthcare Sees Opportunities for More Acquisitions

Molina Healthcare surpassed analyst earnings expectations for the first quarter and detailed a mergers and acquisition environment that may lead to deals in the future. CEO Joe Zubretsky said the insurer is “actively engaged” in seeking out more acquisitions, like its purchase of ConnectiCare, a Connecticut-based health plan from EmblemHealth, last year. “On the M&A

Molina Healthcare Sees Opportunities for More Acquisitions Read More »

PDS Health Targets Growth, Integrated Care in 2025

Continuing last year’s momentum of rapid network expansion and dental-medical integration is the top priority for Henderson, Nev.-based PDS Health in 2025. The integrated healthcare services organization surpassed the 1,000-practice milestone, reported double-digit financial growth and completed more than 7 million patient visits in 2024 and is carrying over that success. Stephen Thorne, the company’s

PDS Health Targets Growth, Integrated Care in 2025 Read More »

Amedisys Sees Revenue Growth as UnitedHealth Group Deal Hangs in the Balance

Amedisys continues to see revenue growth in the midst of its pending acquisition by UnitedHealth Group (NYSE: UNH). The company’s net service revenue rose $23.4 million to $594.8 million in the first quarter of the year compared to $571.4 million in Q1 2024. Net income for Q1 reached $61 million, up from $14.4 million year

Amedisys Sees Revenue Growth as UnitedHealth Group Deal Hangs in the Balance Read More »

HCA Healthcare Beats Profit Estimates on Strong Demand for Medical Care

Hospital operator HCA Healthcare beat Wall Street estimates for first-quarter profit on Friday, as more people underwent elective procedures. U.S. hospitals have been benefiting from elevated demand for non-urgent procedures, particularly from older people, since the second half of 2023. Health insurance bellwether UnitedHealth Group last week flagged a surge in demand for medical care

HCA Healthcare Beats Profit Estimates on Strong Demand for Medical Care Read More »

Germany’s Merck Says in Late-Stage Discussions to Buy SpringWorks for $3.5B

Germany’s Merck KGaA (MRCG.DE) said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics (SWTX.O) for about $3.5 billion, a deal that could give it access to a recently approved rare disease drug and expand its portfolio of experimental cancer treatments. Merck said that the companies are in discussions on the basis

Germany’s Merck Says in Late-Stage Discussions to Buy SpringWorks for $3.5B Read More »

PitchBook’s Q1 2025 Medtech Public Comp Sheet and Valuation Guide

Despite a rocky quarter for public equities, the medtech sector showed relative resilience in Q1 2025. While broader indexes such as the S&P 500 and Nasdaq posted losses, about half of large public medtech companies managed to log gains—boosting the sector’s median performance above the market average. Volatility was sharpest in life sciences, with Tempus

PitchBook’s Q1 2025 Medtech Public Comp Sheet and Valuation Guide Read More »

VMG Health: 2025 Healthcare M&A Report

Despite challenges in 2024, including persistent inflation, rising interest rates, and global economic instability, the value of health services M&A deals increased overall. While the total number of transactions has declined, high-value strategic deals are still commanding strong valuations. Take a look at 2024 insights and predictions for the 2025 M&A landscape. This annual report

VMG Health: 2025 Healthcare M&A Report Read More »

Scroll to Top